Maravai Lifesciences Holdings (MRVI) Profit After Tax (2020 - 2026)

Maravai Lifesciences Holdings' Profit After Tax history runs 7 years deep, the most recent figure standing at -$6.4 million for Q1 2026.

• In Q1 2026, Profit After Tax rose 78.7% year-over-year to -$6.4 million; the TTM figure through Mar 2026 stood at -$84.3 million (up 64.6% YoY), while the FY2025 annual figure was -$130.8 million, up 9.72% from the prior year.
• Profit After Tax for Q1 2026 stood at -$6.4 million, down from $37.0 million in the prior quarter.
• The five-year high for Profit After Tax was $308.1 million in Q4 2022, with the low at -$172.5 million in Q3 2024.
• The 5-year median for Profit After Tax is -$11.9 million (2023), against an average of $1.0 million.
• The sharpest annual moves came in 2024 and 2025: Profit After Tax slumped 1041.93% in 2024, then surged 242.73% in 2025.
• Maravai Lifesciences Holdings' Profit After Tax stood at $308.1 million in 2022, then plunged by 135.7% to -$110.0 million in 2023, then soared by 76.45% to -$25.9 million in 2024, then soared by 242.73% to $37.0 million in 2025, then slumped by 117.25% to -$6.4 million in 2026.
• Business Quant data shows MRVI's Profit After Tax at -$6.4 million in Q1 2026, $37.0 million in Q4 2025, and -$45.1 million in Q3 2025.